甲状腺功能与冠心病及病变支数的相关性研究

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (556 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the correlation of thyroid function in normal range of thyroid stimulating hormone (TSH) with coronary heart disease and the number of lesion vessel. Methods A total of 258 inpatients in the Department of Cardiaology, Mentougou District Hospital of Beijing from January to Decmber in 2018 were retrospectively studied. According to the results of angiography, they were divided into coronary heart disease group(172 cases) and non-coronary heart disease group (86 cases). According to the number of stenosed coronary vessels, they were divided into 0 vessel group (86 cases), 1 vessel group (60 cases), 2 vessels group (56 cases) and 3 vessels group (56 cases). Fasting blood was collected to detect thyroid function related indicators total triiodothyronine (TT3), free T3 (FT3), free thyroxine (FT4) and TSH. and the differences and correlation analysis of each index between groups were compared. Results The level of TSH in coronary heart disease group was higher than that in non-coronary heart disease group, the difference was statistically significant (P ＜ 0.05). Univariate regression analysis showed that TSH (OR = 1.385, 95%CI:1.068-1.797, P ＜ 0.05), and multivariate regression analysis showed that TSH (OR = 1.362, 95%CI: 1.049-1.768, P ＜ 0.05) was an independent risk factor for coronary heart disease. There were statistically significant differences in TSH among groups with 0, 1, 2 and 3 vessel lesions groups (P ＜ 0.05). In univariate linear regression analysis, TSH (β=0.303, 95%CI: 0.172-0.433, P ＜ 0.001) and the number of coronary artery lesions. Multiple linear regression analysis showed that the regression equation was: the number of coronary artery lesions =0.669+0.316×TSH. Conclusion TSH level in the normal range is an independent risk factor for CHD, and has a linear correlation with the number of coronary artery lesions

Key words： Thyroid function Thyroid stimulating hormone Coronary heart disease Number of stenosed coronary vessels

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Jiadan1
	2 PAN Liming1
	2 WANG Jun1
	2 XU Yong3

Cite this article:

LI Jiadan1,2 PAN Liming1,2 WANG Jun1, et al. The correlation of thyroid function with coronary heart disease and lesion numbers[J]. 中国医药导报, 2022, 19(23): 44-48.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I23/44

[1] Ahmadi N，Ahmadi F，Sadiqi M，et al. Thyroid gland dysfunction and its effect on the cardiovascular system： a comprehensive review of the literature [J]. Endokrynol Pol，2020，71（5）：466-478.
[2] Ortolani PD Jr，Romaldini JH，Guerra RA，et al. Association of serum thyrotropin levels with coronary artery disease documented by quantitative coronary angiography：a transversal study [J]. Arch Endocrinol Metab，2018，62（4）：410-415.
[3] Li H，Cui Y，Zhu Y，et al. Association of high normal HbA1c and TSH levels with the risk of CHD：a 10-year cohort study and SVM analysis [J]. Sci Rep，2017，27（7）：45406.
[4] Yang L，Zou J，Zhang M，et al. The relationship between thyroid stimulating hormone within the reference range and coronary artery disease：impact of age [J]. Endocr J，2013，60（6）：773-779.
[5] Li L，Cai GJ，Lu W，et al. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk [J]. BMC Cardiovasc Disord，2021，21（1）：504-510.
[6] Manolis AA，Manolis TA，Melita H，et al. Subclinical thyroid dysfunction and cardiovascular consequences： An alarming wake-up call? [J]. Trends Cardiovasc Med，2020， 30（2）：57-69.
[7] Floriani C，Gencer B，Collet TH，et al. Subclinical thyroid dysfunction and cardiovascular diseases：2016 update [J]. Eur Heart J，2018，39（7）：503-507.
[8] Rodondi N，Newman AB，Vittinghoff E，et al. Subclinical hypothyroidism and the risk of heart failure，other cardiovascular events and death [J]. Arch Intern Med，2005，165（21）：2460-2466.
[9] Asvold BO，Bj?覬ro T，Platou C，el al. Thyroid function and the risk of coronary heart disease： 12-year follow-up of the HUNT Study in Norway [J]. Clin Endocrinol（Oxf），2012，77（6）：911-917.
[10] 马丽媛，吴亚哲，陈伟伟.《中国心血管病报告2018》要点介绍[J].中华高血压杂志，2019，27（8）：712-716.
[11] Paschou SA，Bletsa E，Stampouloglou PK，et al. Thyroid disorders and cardiovascular manifestations： an update [J]. Endocrine，2022，75（3）：672-683.
[12] Borisov DV，Gubaeva DN，Praskurnichiy EA. Use of thyroid hormones in the treatment of cardiovascular diseases： literature review [J]. Probl Endokrinol（Mosk），2020，66（3）：6-14.
[13] Límanová Z，Jiskra J. Thyroid hormones and cardiovascular systemVnitr Lek [J]. Vnitr Lek，2016，62（9 Suppl 3）：92-98.
[14] Jabbar A，Pingitore A，Pearce SH，et al. Thyroid hormones and cardiovascular disease [J]. Nat Rev Cardiol，2017，14（1）：39-55.
[15] Vale C，Neves JS，von Hafe M，et al. The Role of Thyroid Hormones in Heart Failure[J]. Cardiovasc Drugs Ther，2019，33（2）：179-188.
[16] Yang G，Wang Y，Ma A，et al. Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction [J]. BMC Cardiovasc Disord，2019，19（1）：83-93.
[17] Spartalis M，Spartalis E，Athanasiou A，el al. The Role of the Endothelium in Premature Atherosclerosis： Molecular Mechanisms [J]. Curr Med Chem，2020，27（7）：1041-1051.
[18] Gong N，Gao C，Chen X，et al. Endothelial Function in Patients with Subclinical Hypothyroidism： A Meta-Analysis [J]. Horm Metab Res，2019，51（11）：691-702.
[19] Cai P，Peng Y，Chen Y，et al. Blood pressure characteristics of subclinical hypothyroidism： an observation study combined with office blood pressure and 24-h ambulatory blood pressure [J]. J Hypertens，2021，39（3）：453-460.
[20] Saric MS，Jurasic MJ，Budincevic H，et al. The role of thyroid hormones in carotid arterial wall remodeling in women [J]. Rom J Intern Med，2022，60（1）：24-33.
[21] Razvi S，Jabbar A，Pingitore A，et al. Thyroid Hormones and Cardiovascular Function and Diseases [J]. J Am Coll Cardiol，2018，71（16）：1781-1796.
[22] Corona G，Croce L，Sparano C，et al. Thyroid and heart，a clinically relevant relationship [J]. J Endocrinol Invest，2021，44（12）：2535-2544.
[23] Asvold BO，Vatten LJ，Nilsen TI，et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study [J]. Eur J Endocrinol，2007，156（2）：181-186.
[24] Tognini S，Polini A，Pasqualetti G，et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile：results from a large cross-sectional study [J]. Thyroid，2012，22（11）：1096-1103.
[25] Wang F，Tan Y，Wang C，et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones [J]. J Clin Endocrinol Metab，2012，97（8）：2724-2731.
[26] Xu C，Yang X，Liu W，et al. Thyroid stimulating hormone，independent of thyroid hormone，can elevate the serum total cholesterol level in patients with coronary heart disease：a cross-sectional design [J]. Nutr Metab（Lond），2012，9（1）：44-52.